ADT intensification to treat biochemically recurrent prostate cancer

被引：0
|
作者：
Masone, Maria Chiara
机构：
[1] Nature Reviews Urology,
来源：
NATURE REVIEWS UROLOGY | 2024年 / 21卷 / 03期
关键词：
D O I：
10.1038/s41585-024-00862-2
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：126 / 126
页数：1
相关论文
共 50 条
  • [1] ADT intensification to treat biochemically recurrent prostate cancer
    Maria Chiara Masone
    Nature Reviews Urology, 2024, 21 : 126 - 126
  • [2] Enzalutamide in Biochemically Recurrent Prostate Cancer
    Pollak, Michael
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (01): : 90 - 90
  • [3] Phase 2 study of olaparib (without ADT) in men with biochemically recurrent prostate cancer (BCR) after prostatectomy
    Marshall, Catherine Handy
    Teply, Benjamin A.
    Lim, Su Jin
    Wang, Hao
    Mao, Shifeng S.
    Kelly, William Kevin
    Paller, Channing Judith
    Markowski, Mark Christopher
    Denmeade, Samuel R.
    Carducci, Michael Anthony
    Eisenberger, Mario A.
    King, Serina
    Sullivan, Rana
    Lotan, Tamara L.
    Antonarakis, Emmanuel S.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] Management Options for Biochemically Recurrent Prostate Cancer
    Farhad Fakhrejahani
    Ravi A. Madan
    William L. Dahut
    Current Treatment Options in Oncology, 2017, 18
  • [5] Management Options for Biochemically Recurrent Prostate Cancer
    Fakhrejahani, Farhad
    Madan, Ravi A.
    Dahut, William L.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2017, 18 (05)
  • [6] Immunotherapy for biochemically recurrent prostate cancer.
    Madan, Ravi Amrit
    Karzai, Fatima
    Bilusic, Marijo
    Strauss, Julius
    Slovin, Susan F.
    Harshman, Lauren Christine
    Theoret, Marc Robert
    Arlen, Philip M.
    Rauckhorst, Myrna
    Couvillon, Anna
    Hankin, Amy
    Williams, Monique
    Kantoff, Philip W.
    Dahut, William L.
    Schlom, Jeffrey
    Gulley, James L.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [7] Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer
    Freedland, Stephen J.
    Luz, Murilo de Almeida
    De Giorgi, Ugo
    Gleave, Martin
    Gotto, Geoffrey T.
    Pieczonka, Christopher M.
    Haas, Gabriel P.
    Kim, Choung-Soo
    Ramirez-Backhaus, Miguel
    Rannikko, Antti
    Tarazi, Jamal
    Sridharan, Swetha
    Sugg, Jennifer
    Tang, Yiyun
    Tutrone, Ronald F.
    Venugopal, Balaji
    Villers, Arnauld
    Woo, Henry H.
    Zohren, Fabian
    Shore, Neal D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (16): : 1453 - 1465
  • [8] A combination herbal supplement for biochemically recurrent prostate cancer
    Dorff, Tanya B.
    Hawes, Debra
    Tsao-Wei, Denice D.
    Quinn, David I.
    Goldkorn, Amir
    Lieskovsky, Gary
    Vogelzang, Nicholas J.
    Groshen, Susan G.
    Pinski, Jacek K.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [9] Investigation of potential biomarkers of biochemically recurrent prostate cancer
    Demidenko, R.
    Daniunaite, K.
    Laurinavicius, A.
    Jankevicius, F.
    Jarmalaite, S.
    Lazutka, J. R.
    FEBS JOURNAL, 2014, 281 : 481 - 481
  • [10] The Potential Role for Immunotherapy in Biochemically Recurrent Prostate Cancer
    Bilusic, Marijo
    Einstein, David J.
    Karzai, Fatima H.
    Dahut, William L.
    Gulley, James L.
    Aragon-Ching, Jeanny B.
    Madan, Ravi A.
    UROLOGIC CLINICS OF NORTH AMERICA, 2020, 47 (04) : 457 - 467
12345